Results 171 to 180 of about 283,560 (208)

Spontaneous Hepatobiliary Disease in a Breeding Colony of Aotus spp.

open access: yesJournal of Medical Primatology, Volume 55, Issue 5, October 2026.
ABSTRACT Background Owl monkeys are nonhuman primate species in the genus Aotus. The Michale E. Keeling Center for Comparative Medicine and Research maintains an Owl Monkey Breeding and Research Resource composed of four species of owl monkeys: Aotus nancymai, A. vociferans, A. azarae, and A. griseimembra.
M. E. Hensel   +4 more
wiley   +1 more source

Immune Interactions Unique to Intradermal Microtoxin: Insights From Aesthetic, Therapeutic, and Vaccination Studies

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 10, October 2026.
ABSTRACT Introduction Intradermal botulinum toxin type A (BoNT‐A; microtoxin) has been shown to improve skin texture, superficial rhytides, and sweat/sebaceous activity through neuronal (cholinergic) and non‐neuronal pathways. While discussions around immune system interactions for BoNT‐A in aesthetic indications exist for intramuscular injection, the ...
Je‐Young Park   +6 more
wiley   +1 more source

Implementing School‐Associated Vaccination Events in Colorado Public Schools: A Statewide Survey of Nurses

open access: yesJournal of School Health, Volume 96, Issue 10, October 2026.
ABSTRACT Background Schools are important settings for delivering vaccines. It is unknown how facilitators of and barriers to implementing school‐associated vaccination events (SAVEs) vary by school‐ and community‐level characteristics. Methods We fielded a web‐based survey of school nurses that worked in Colorado public schools in Fall 2024 to assess ...
Liliane Nienstedt   +3 more
wiley   +1 more source

Estimating the Fraction of Hepatocellular Carcinoma and Decompensated Cirrhosis Attributable to Viral Hepatitis in England Using Electronic Health Records and Case‐Notes Review

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 10, October 2026.
ABSTRACT Viral hepatitis mortality is an impact target required to evidence the elimination of viral hepatitis with a combined mortality rate of less than or equal to six deaths per 100,000 population. Within England, routine healthcare data linked with death registrations are used; however, where these data are not available, the World Health ...
David Etoori   +15 more
wiley   +1 more source

EuroHePP: The European Toolkit to Strengthen National Responses for the Elimination of Viral Hepatitis in Prisons

open access: yesLiver International, Volume 46, Issue 10, October 2026.
ABSTRACT People living in prison are disproportionately affected by hepatitis B and C, yet access to prevention, testing, and treatment services remains inconsistent across Europe. Addressing this gap is critical to achieving viral hepatitis elimination targets by 2030.
Serena Fondelli   +23 more
wiley   +1 more source

Nanomaterial Strategies for Pulmonary Delivery of Immunotherapeutics in Lung Cancer Treatment

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 34, 11 September 2026.
Inhalable immunotherapeutic nanomedicines enable organ‐selective immune modulation by overcoming pulmonary delivery barriers and concentrating therapy within lung tumors. This Review defines how nanomaterial properties govern airway deposition, retention, cellular partitioning, and immune activation across vaccines, checkpoint blockade, STING agonists,
Han Zhang, Wei Tang
wiley   +1 more source

Targeting p21‐High Senescent Kupffer Cells Nanotherapeutically Potentiates Antitumor Immunity in Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

open access: yesAdvanced Science, Volume 13, Issue 54, 28 September 2026.
Schematic illustration of a biomimetic SKEV@AAV platform targeting p21‐high senescent Kupffer cells (sKCs) in hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). p21‐high sKCs accumulate in the PVTT microenvironment and establish an immunosuppressive, SASP‐rich environment that facilitates tumor cell proliferation and immune evasion.
Na Ta   +10 more
wiley   +1 more source

Engineering CAR‐Macrophages With Advanced Delivery Systems for Tissue Repair

open access: yesAdvanced Science, Volume 13, Issue 51, 14 September 2026.
This review highlights how engineered macrophages equipped with chimeric antigen receptors (CAR) guide tissue repair by recognizing disease‐related targets, clearing harmful cells, and reshaping local immune environments. It summarizes macrophage biology, CAR design, delivery platforms, and functionalization strategies, and discusses emerging ...
Yixin Zhang   +8 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Vogt-Koyanagi-Harada Disease Associated with Hepatitis B Vaccination

Ocular immunology and inflammation, 2018
Purpose: To report a case of Vogt–Koyanagi–Harada (VKH) disease associated with hepatitis B vaccination. Methods: Case report. Results: A 43-year-old Caucasian male presented with a three-week history of blurry vision, pain, photophobia, and redness in ...
Arjun B. Sood   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy